Promising clinical trial results of tucatinib with T-DM1 against HER2+ breast cancer
Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1…
Phase 1b clinical trial results published in JAMA Oncology show promise for the combination of tucatinib (formerly ONT-380) with T-DM1…
Preliminary data from the first clinical trial of the company’s intracranial ultrasound implant, SonoCloud®, show a good safety profile and…
The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for…